Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Inventory (2016 - 2025)

CV Sciences' Inventory history spans 13 years, with the latest figure at $4.1 million for Q4 2025.

  • On a quarterly basis, Inventory fell 16.54% to $4.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.1 million, a 16.54% decrease, with the full-year FY2025 number at $4.1 million, down 16.54% from a year prior.
  • Inventory hit $4.1 million in Q4 2025 for CV Sciences, roughly flat from $4.1 million in the prior quarter.
  • Over the last five years, Inventory for CVSI hit a ceiling of $9.2 million in Q2 2021 and a floor of $4.1 million in Q3 2025.
  • Historically, Inventory has averaged $6.3 million across 5 years, with a median of $5.8 million in 2023.
  • Biggest five-year swings in Inventory: rose 9.0% in 2021 and later fell 24.11% in 2025.
  • Tracing CVSI's Inventory over 5 years: stood at $8.6 million in 2021, then decreased by 23.9% to $6.6 million in 2022, then decreased by 13.84% to $5.7 million in 2023, then fell by 13.4% to $4.9 million in 2024, then dropped by 16.54% to $4.1 million in 2025.
  • Business Quant data shows Inventory for CVSI at $4.1 million in Q4 2025, $4.1 million in Q3 2025, and $4.2 million in Q2 2025.